Emergency: 9010550550
24/7 Service

Menopause Care

IMS/FOGSI-aligned symptom control, bone health and heart risk prevention with clear follow-ups

Book Menopause Consultation
80–90%
Hot-flash relief
With tailored therapy at 8–12 weeks
24–48 hrs
Report turnaround
DEXA, mammography and key labs routed to EMR
30–50%
Fracture risk drop
With combined lifestyle + pharmacotherapy over 1–3 years

When to Consult

  • Bothersome hot flashes/night sweats affecting sleep or work
  • Vaginal dryness or painful intercourse (GSM symptoms)
  • Mood changes, brain fog or poor sleep quality
  • Irregular/heavy bleeding after 40 or any postmenopausal bleeding
  • Family/personal risk of osteoporosis or low-trauma fracture
  • High BP, high cholesterol, diabetes or weight gain around menopause

Understanding Menopause in the Indian Context

In Hyderabad and Telangana, hot weather, shift-work and festival routines can worsen vasomotor symptoms, sleep and weight. Family and work demands make it easy to ignore bleeding changes or bone health. Ajuda’s program blends lifestyle, safe medications and screening to keep you active and confident.

When to Consult Our Menopause Specialists

  • ✓ Hot flashes/night sweats disturbing sleep/work
  • ✓ Vaginal dryness, pain or urinary urgency
  • ✓ Mood changes, anxiety or brain fog
  • ✓ Heavy/irregular bleeding after 40 or any postmenopausal bleeding
  • ✓ Low-trauma fracture or strong family osteoporosis history
  • ✓ High BP, high cholesterol, diabetes or weight gain

Our Diagnostic Approach

Comprehensive Baseline

History, risk tools and vitals; align with IMS guidance.

Labs & Imaging

CBC, TSH, glucose/HbA1c, lipids, vitamin D; TVS for bleeding; age-appropriate breast screening.

Bone Health

DEXA + FRAX to classify fracture risk and target therapy.

Personalised Plan

Choose lifestyle, non-hormonal care, HRT/GSM options and heart-risk control with clear milestones.

Treatment Pathways

We start with lifestyle and symptom relief, then tailor HRT if eligible after risk review. GSM care uses local oestrogen and pelvic floor therapy. Bone protection and heart-metabolic control run in parallel. Tele follow-ups adjust doses, track side-effects and keep screening on schedule.

What to Expect: Your Care Journey

First visit covers evaluation and counselling. By 6–8 weeks most women see symptom relief; by 3–6 months, sleep, energy and metabolic markers improve. Annual reviews include DEXA and screening checks. WhatsApp check-ins support daily questions.

Technology & Innovation

DEXA, mammography and labs flow into EMR dashboards for trend-based decisions. This helps us titrate HRT safely, track fracture risk and send reminders for vaccines and screening.

Preventing Complications

We proactively address fractures, heart disease, depression and GSM-related UTIs. Early evaluation of abnormal bleeding rules out serious causes and keeps treatment safe.

Why Ajuda for Menopause Care?

🧭 Personalised, guideline-aligned plans
🦴 DEXA-guided bone protection
💬 Multilingual counselling & WhatsApp follow-ups

Take the First Step

Menopause is manageable. Call 9010550550 or message on WhatsApp to plan safe, comfortable care with Ajuda.

Diagnosis Approach

1

Comprehensive baseline assessment

History, BP/BMI, cycle status, medication review and risk tools; align with Indian Menopause Society (IMS) guidance.

2

Screening labs & imaging

CBC, TSH, fasting glucose/HbA1c, lipid profile, vitamin D; TVS for abnormal bleeding; mammography/USG breasts as age-appropriate.

3

Bone health evaluation

DEXA scan with FRAX-based fracture risk; calcium/vitamin D review and secondary causes screen.

4

Individualised plan & counselling

Discuss HRT eligibility/contraindications, non-hormonal options, GSM therapy and cardiometabolic risk control.

Treatment Options

Lifestyle & Nutrition Coaching

South-Indian meal plans, protein targets, low-sodium pickle swaps, resistance training and sleep hygiene.

Reduces vasomotor symptoms and improves lipids/glucose.
8–12 weeks with monthly reviews

Non-Hormonal Symptom Relief

SSRIs/SNRIs, gabapentin or clonidine when HRT is unsuitable; cognitive and sleep strategies.

Meaningful hot-flash reduction in many patients.
Trial 6–12 weeks then reassess

Personalised HRT

Transdermal/oral oestrogen with progesterone if uterus present; start if eligible (<60 yrs or within 10 yrs of menopause) after risk review.

Highest efficacy for vasomotor symptoms and bone preservation.
Dose-titrated with 3–6 month reviews

GSM Care (Vaginal Oestrogen & Pelvic Floor)

Local oestrogen, moisturisers, pelvic floor therapy and lubricants for dryness, urgency and dyspareunia.

High local symptom control with minimal systemic effects.
Continuous with periodic checks

Bone Health Program

Calcium/vitamin D, weight training, fall-risk fixes; bisphosphonates/denosumab/endocrine referral when indicated.

Improves BMD and lowers fracture risk.
6–12 months then annual DEXA review

Heart & Metabolic Risk Pathway

BP, lipids, diabetes control; weight, thyroid and sleep apnoea screening with cardiology as needed.

Lowers long-term CV events and improves energy.
Quarterly reviews; annual comprehensive check

Expected Outcomes

Treatment Timeline

2–4 Weeks

Lifestyle plan started; initial symptom relief and sleep improvements.

6–8 Weeks

HRT/non-hormonal regimen stabilised; GSM symptoms easing.

3–6 Months

Sustained hot-flash control; weight and lipid/HbA1c trending better.

1 Year+

DEXA/BMD stabilised; fracture and CV risk lowered; annual screening on track.

Success Metrics

  • ≥50% reduction in hot-flash frequency
  • LDL/HbA1c improvement vs baseline
  • DEXA T-score stabilisation and no new low-trauma fractures